Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulfide:quinone oxidoreductase (SQR) is an integral peripheral membrane enzyme that catalyzes the oxidation of sulfide ions to elemental sulfur, transferring electrons to membrane quinones such as ubiquinone, menaquinone, or plastoquinone. The enzyme contains a covalently bound FAD cofactor and conserved cysteine residues crucial for its catalytic mechanism, which involves the formation of sulfur bridges and polysulfur chains at the active site. SQR plays a vital role in sulfide detoxification and in mitochondrial and microbial energy metabolism, supporting ion gradient formation for ATP synthesis. Its structural family is closely related to other disulfide oxidoreductase flavoproteins, and its activity is essential for survival in sulfide-rich or hypoxic environments. Increased SQR expression mediates protection against hypoxia in animal models. Inhibitors such as Aurachin C can competitively block the quinone-binding site, impeding the electron transfer essential for its function. Dysfunction or inhibition of SQR may contribute to energy metabolism disorders and heightened toxicity due to sulfide accumulation.
Inhibitors block electron transfer to quinone (e.g., competitive inhibition at the quinone binding site). Drugs could act by preventing sulfide oxidation or interfering with energy/redox balance; no FDA-approved drugs target SQR directly at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfide:quinone oxidoreductase (SQR).